Abstract

This review article describes the current status and future perspectives of site-specific drug delivery by means of macromolecular carrier systems. Basic aspects and recent advances of targeted delivery of 1) conventional drugs, 2) protein drugs, and 3) gene medicines including antisense oligonucleotides and plasmid DNA, are reviewed from a pharmacokinetic perspective. Successful in vivo application of macromolecular carrier systems requires pharmacokinetic considerations at whole body, organ, cellular and subcellular levels. The integration of simultaneous research progress in the multidisciplinary fields such as biochemistry, cell and molecular biology, pharmacology, and pharmacokinetics will accelerate the emergence of marketed drugs with macromolecular carrier systems.

Keywords

BiodistributionDrug deliveryPharmacokineticsDrug carrierPharmacologyComputational biologyDrugIn vivoChemistryNanotechnologyBiologyBiotechnologyMaterials science

MeSH Terms

AnimalsDrug CarriersDrug Delivery SystemsHumansMacromolecular SubstancesPharmacokineticsTissue Distribution

Affiliated Institutions

Related Publications

Publication Info

Year
1996
Type
review
Volume
13
Issue
6
Pages
820-831
Citations
223
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

223
OpenAlex
2
Influential
185
CrossRef

Cite This

Yoshinobu Takakura, Mitsuru Hashida (1996). Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution. Pharmaceutical Research , 13 (6) , 820-831. https://doi.org/10.1023/a:1016084508097

Identifiers

DOI
10.1023/a:1016084508097
PMID
8792417

Data Quality

Data completeness: 81%